Delivery Order SPE2DB22D3016-SPE2DB25FAJQ5

Award Date 1/9/25
Potential Completion Date 1/31/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,113.38 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,809.20 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,213.60 firm fixed-price delivery order is for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a completion date of July 26, 2022 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The contract is a firm fixed-price Delivery Order with a ceiling value of $4,754.64 and an ultimate completion date of February 13, 2025. The contract is not set aside for any specific business category....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $13,606.80 firm-fixed-price contract has an ultimate completion date of March 1, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a $13,618.40 delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. The firm-fixed-price contract runs through July 25, 2024 and was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 100 milligram vials of the COVID-19 treatment medication Veklury (Remdesivir) with a potential value of $13,618.40 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the antiviral drug VEKLURY (Remdesivir) in 100 mg vials. The $2,042.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of Veklury (Remdesivir) 100 mg vials, a treatment for COVID-19. The contract has a ceiling value of $6,809.20 and runs through July 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAJQ5
    Delivery Order

This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAJQ5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,848.80 firm-fixed-price delivery order is for the supply of Veklury (remdesivir) 100 mg vials, a critical medication used in the treatment of COVID-19.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, encompasses a wide array of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for fulfilling this order for the Veklury medication. The delivery of these critical COVID-19 treatment vials supports the federal government's efforts to ensure the availability of essential medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/10/25, 11:31 AM